Beta-blockers have been a common cardiovascular drug for years, but more and more, doctors are turning to these heart drugs to treat anxiety.

Researchers engineered CD4+ chimeric antigen receptor T cells targeting fibrillar amyloid beta and tested them in a mouse ...

Modified molecule shows diminished respiratory depression—the leading cause of opioid overdose deaths—while retaining full ...

Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announced that the ...

T cell therapy, a type of immunotherapy that leverages the immune system to combat diseases, is a powerful treatment option ...

If alpha and beta receptors make you panic, listen to this ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Pulmonary hypertension (PH) due to left heart disease (group 2 PH) is associated with a worse prognosis than isolated heart failure. Both pulmonary arterial hypertension (group 1 PH) and group 2 PH ...